L8: Antibodies and Immunoassays Flashcards

1
Q

Define immunity and list immune cell types.

A
• Composed of effector cells and molecules
– Recognition
– Effector functions
– Regulation
– Memory
Immune cells
• Leukocytes (or White Blood Cells)
– Myeloid (bone marrow) or Lymphoid
– Granulocytes or Agranulocytes

See slide 6 for hematopoesis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

List immune molecules integral to cellular response.

A

• Cytokine: secreted proteins that affect the behaviour of
neighbouring cells
• Chemokine: secreted proteins that act as
chemoattractants (i.e. attract neutrophils out of the
blood and into infected tissue)
• Complement: a group of over 30 proteins involved in
the killing of pathogens

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Describe the basics of innate and adaptive immune response.

A

Innate
• Immediately available
• Non-specific
• Lacks ‘memory’
• Innate defences control pathogens that carry certain
molecular patterns or that induce other non-specific
defences
‒ Pathogen-associated molecular patterns [PAMPs])
• Toll-like receptors (TLRs)
• Pattern recognition receptors (PRRs)

Adaptive
• Has to be developed
• Response to a specific infection
• Has ‘immunologic memory’; can confer lifetime
protection
• Adaptive immunity is required to recognize and battle the
wide array of pathogens present

Each consists of a humoral and cellular component (humor = cell-free bodily fluid) (see slide 9 for time response)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Provide examples of PAMPs.

A
Bacterial Lipopolysaccharides (LPS) (a.k.a.
Endotoxins)
‒ Prototypical PAMPs
‒ Outer membranes of Gram-negative bacteria
•
Other PAMPs include:
‒ Bacterial flagellin
‒ Lipoteichoic acid (Gram+)
‒ Petidoglycan (Gram+)
‒ Chitin (fungi)
‒ dsRNA (viruses)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Define antigen and antibodies.

A

Antigen
• A molecule, or part thereof, that is specifically recognized
by the recognition proteins of lymphocytes
‒ B-cells have membrane bound B-cell receptor (BCR)

Antibody
• Produced by Plasma cells (terminally differentiated B-cells)
• Bind specifically to a pathogen, or pathogen product, that
produced the immune response
• Recruit other cells/molecules to destroy the pathogen

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Describe three roles of antibodies.

A
  • Neutralization
  • Opsonization
  • Compliment Activation

(14-16)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Describe the structure of an antibody.

A

An antibody, also known as an immunoglobulin, is a Y-shaped structure which consists of four polypeptides — two heavy chains and two light chains. This structure allows antibody molecules to carry out their dual functions: antigen binding and biological activity mediation.

Variable region
• Defines antigen specificity and binds to the antigen

Constant region
• Determines the isotype/allotype
• Recruits effector molecules

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Define antibody isotype and subclasses.

A
Isotypes
• Five heavy chain (g, a, μ, d, e) and two light chain (k, l)
• Heavy chain isotype determines the class of Ig

Subclasses
• Encoded by separate genes
• Four IgG (1-4)
‒ IgG1 is most abundant and makes up ~70% of IgG
• Two IgA (1-2)
‒ IgA2 is minor component in serum but major in
secretions

(see slide 22)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Define allotype and idiotype.

A

Allotype
• Allelic variations found in the constant region
‒ Can be antigenic determinants
Idiotype
• Differences due to rearrangement of the variable regions
‒ Specific to each Ig molecule

Anti-idiotypic antibodies
Epitope is part of the variable region of other antibodies
Two types:
• Alpha
‒ Recognizes epitopes in variable region
‒ Insensitive to Ab-Ag interaction of target antibody
• Beta
‒ Recognizes the paratope
‒ Sensitive to Ag-Ab interaction of target antibody
(does not bind if Ag is bound)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Describe antibody fragments.

A

cleaved into functional fragments
• Fragment antigen binding (Fab)
• Fragment crystallizable (Fc)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Define antigen and describe the difference between immunogen and hapten.

A

Any substance that can bind to an antibody
Immunogen
• Can induce an adaptive immune response
Hapten
• A small molecule that is unable to elicit an immune
response on its own
‒ When coupled to a carrier, it is able to do so
‒ The carrier does not have to be immunogenic

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Describe immunogenic factors of antigen.

A

see slide 27

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Define epitope.

A

Epitope (Antigenic Determinant)
• The part of the antigen that the antibody binds to

Epitopes on proteins can be:
• Continuous/linear
‒ Made up of a single segment of a polypeptide chain
• Discontinuous/conformational
‒ Composed of amino acids from different parts of the polypeptide chain that are brought together by protein folding

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Define paratope

A

Paratope
• The part of the antibody that binds the epitope

Each variable region has hyper-variable regions which are responsible for antigen recognition and binding

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Describe binding of antibody to antigen reaction and the factors impacting the strength of the reaction. What is the Scatchard model?

A

Binding of Ab to Ag is reversible and obeys the law of mass action:
• The rate of the reaction is proportional to the concentration of the reactants

The strength of the interaction is based on the ‘fit’ of the epitope and paratope
Non-covalent forces:
• Electrostatic (1/d2)
• Hydrogen bonds (stronger at colder temp)
• Van der Waals forces (1/d6)
• Hydrophobic forces (provide up to 50% strength in interaction)

Real Ab-Ag interactions are complicated

The Scatchard model is used for the quantitative description of the multiple
equilibria occurring
• Assumes independent and noninteracting binding sites

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Describe affinity.

A

The strength of binding between a single epitope - paratope complex
‒ Determined by the equilibrium constant of the association
reaction between antibody (Ab) and antigen (Ag)

(see equation on Slide 34)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Describe avidity.

A

Avidity (a.k.a. functional affinity)
• The strength of interaction between an antigen with multiple epitopes to an antibody with multiple paratopes

Multiple interactions are involved making accurate modeling of the interaction difficult
• Avidity can be many times greater than the sum of affinities
‒ When multiple interactions are present (i.e. IgM with a bacterium) the probability that every interaction will dissociate simultaneously is exceedingly small)
(see slide 39 for equation)

18
Q

What factors include Ag-Ab interactions in vitro?

A

• Synergistic effects (Avidity)
• pH, Temperature and Ionic strength of the solution
‒ Cationic salts inhibit binding with cationic haptens and anionic
salts inhibit binding with anionic haptens
• Cs+ > Rb+ >NH4+ > K+ > Na+ > Li+
• SCN- > NO3- > I- > Br- > Cl- > F-
• Polymer effect
‒ Soluble linear high MW polymers increase the effective
concentration of Ag and Ab and increase the rate of complex
formation (i.e. PEG 6000)
• Relative [Ab] and [Ag]
• Higher concentrations lead to increase rate of reaction

19
Q

Define cross vs shared reactivity.

A

Cross reactivity
• Binding of structurally different epitopes by the same antibody (different affinities)

Shared reactivity
• Common epitopes on different antigens

20
Q

List the antibody requirements for immunoassays.

A
  • Reproducible
  • Specific
  • High Affinity
  • Stable
  • Large-scale production
  • Readily purified
21
Q

Describe antibody clonality.

A
  • Antibodies are produced plasma cells (terminally differentiated B-cells)
  • Each B-cell encodes a single unique immunoglobulin
  • Plasma cells originating from the same B-cell produce identical antibodies and are ‘clones’ of each other

Monoclonal antibodies
‒ Generated from a single plasma cell clone
Polyclonal antibodies
‒ Generated from multiple plasma cell clones

22
Q

Describe polyclonal antibodies and their characteristics.

A

‒ Generated from multiple plasma cell clones
• Classical immune response to an antigen
• An animal is immunized and bled and the resulting antiserum is used as the reagent
‒ Rabbits, sheep, goats, donkeys
• The larger the animal, the more serum that can be collected but the harder they are to maintain

Polyclonal antisera:
• Reacts with several epitopes on the antigen
• Includes antibodies of varying specificities and affinities
• Includes antibodies of varying classes and subclasses
• Will include a wide variety of irrelevant antibodies (unless purified and/or animal is kept in sterile conditions)
• Will vary in antibody composition each time it is collected from an animal
• Have a finite supply (depends on lifespan of the animal)
• Are relatively inexpensive to produce

23
Q

Describe monoclonal antibodies and their characteristics.

A

• Artificial way to produce antibodies from a single clone of plasma cells
• B-cells are cultured from the spleen of an immunized animal, immortalized, isolated and used to produce antibodies
‒ Mice, rabbits, humans
‒ Size of the animal does not matter (cells culture)

  • React with a single epitope on an antigen
  • Include a single antibody of a defined class and subclass
  • Include a single antibody of a defined specificity and affinity
  • Does not include any irrelevant antibodies
  • Are completely reproducible
  • Have an infinite supply available
  • Are expensive to produce
24
Q

In antibody production, how do you choose choice of animal?

A

• Animals used need to be healthy
• Gender does not matter
‒ Except when sharing cages (i.e. male mice are more aggressive; injuries may lead to infections)
• Older animals generally have poorer immunologic response to injected antigens
• The species used will depend on the type and amount of antibody you need

Polyclonal
• Rabbits are most common (low maintenance costs)
• Larger animals are generally used for secondary Ab
production with broad uses (e.g. goat anti-mouse IgG)
• Animals are genetically outbred with respect to MHC antigens; each reacts differently to an antigen

Monoclonal
• Usually Mouse (most popular), Rat or Human
• Require inbred animals in order to produce hybridomas
• Human hybridomas may be chimeric (rodent-human)

25
In antibody production, what are common considerations in immunization procedures?
Size of the Antigen • All natural B cell antigens are large and so antigens must be presented in this context • Small molecules that cannot elicit an immune response (haptens) need to be coupled to a carrier ‒ BSA, ovalbumin, or keyhole limpet hemocyanin (KLH) Chemical nature of the Antigen • Carbohydrates elicit a large B cell response • Proteins: lower homology à larger response • Nucleic acids and lipids are poor antigens on their own Adjuvants • Used as an immunopotentiator • Slows the release of antigens (mimicking natural antigens) thus increases immune response • Addition of bacteria to adjuvants were thought to increase the immune response, but may actually divert the response away from your antigen ‒ Most common is complete Freund’s adjuvant (CFA) which is suspension of killed mycobacteria in mineral oil. Incomplete Freund’s adjuvant (IFA) is the mineral oil without bacteria ``` Route of immunization • Subcutaneous ‒ Most commonly used ‒ Used for soluble antigens emulsified with CFA or IFA • Intraperitoneal ‒ Used for cellular antigens in mice • Intravenous ‒ May be used for final boost ``` Amount of Antigen • Immune response does not directly correlate with the amount of antigen and large amounts will not provide a better response
26
Describe important considerations for antibody purification.
Degree of purification depends on the intended use • Unlabeled immunoassay: limited purification • Labeled: ≥80% purity • In vivo: completely pure Contaminants • Serum: Albumin (50%); Other Ig (12-25%) • Cell culture: FBS; other proteins (secreted, shed)
27
Describe types of antibody purification.
Typical rough purification techniques include: 1. Ammonium Sulfate Precipitation • Nonselective precipitation • Used more for concentration of Ab 2. DEAE and QAE Columns • Positively charged columns used primarily to remove albumin (anion exchange) More selective purification can be performed using Protein A, G or L • Bacterial proteins that bind to mammalian immunoglobulins • A and G bind to the Fc region of IgG (A binds weakly to IgG3, G binds strongly to all subclasses and is better at binding mouse IgG) • L binds to variable region of kappa • Provides rough purification for polyclonal Ab Selective purification can be achieved by affinity chromatography ‒ Negative selection: use carrier bound to a solid support and keep the flow through ‒ Positive selection: use your antigen bound to a solid support, wash off all non-specific proteins and elute your Ab of interest
28
Describe considerations for storage of antibodies.
• IgG are very stable; can maintain activity for weeks at RT • Antibodies collected as serum (polyclonal) or culture media (monoclonal) contain proteases and may be nonsterile and need to be processed ‒ Heat to 60 oC for 5’-10’ to inactivate most proteases ‒ Store frozen (-70 oC) to minimize proteolytic activity ‒ Add chemicals to inhibit bacterial growth or protease activity
29
Describe different types of isotopic antibody labelling.
Internal Labels • Existing atom in a molecule is replaced by a radioactive isotope of the same atom External Labels • More common than internal labels • Radioactive isotope is covalently linked to the molecule • Most common is 125I; others include 3H,131I, 57Co, 75Se, 32P • More being replaced by non-isotopic (external) labels
30
Describe direct iodination and conjugation labelling.
Direct Iodination • Iodine can be incorporated into the aromatic ring of tyrosine residues • May also be incorporated into other aromatic side chains (H, F and W) but reaction is 30-80x less efficient Conjugation labeling • Carrier that incorporates a phenol or imidazole group that can be iodinated, and an amine group that can be coupled directly to carboxyl groups on the ligand
31
What are the benefits and limitations of conjugation labelling?
``` Pros • Does not require tyrosine • Can be used on nonpeptides • Simple to perform • Not very damaging to the ligand ``` Cons • Larger than an individual iodine atom; may alter the properties of the tracer
32
What are some types of non-isotopic labels?
Label - Example Chemiluminescent - Acridium ester, isoluminol Electrochemiluminescent - Ruthenium complexes Cofactor - ATP, NAD Enzyme - ALP, b-gal, G6PD, HRP Fluorophore - Europium chelate, fluorescein, phycoerythrin * Unlike radioisotopic labels, they are not single atoms * Covalently linked (conjugated) to the Ab/Tracer
33
Describe using primary amines for conjugation labelling.
* Most common target * Found on lysine and the N-terminus of each polypeptide chain. * Usually outward facing on proteins and available for conjugation * Abundant, widely distributed and easily modified * Several chemistries available * N-hydroxysuccinimidyl ester (NHS) * Glutaraldehyde
34
Describe using sulfhydryl groups for conjugation labelling.
* In native proteins, -SH are commonly found in the oxidized form (disulfide bonds) which participate in tertiary and quaternary protein structure * Conjugation requires thiols be present in sulfhydryl form, so reducing agents necessary * Several chemistries exist * Maleimide * Iodoacetyl
35
Describe using carbonyl groups for conjugation labelling.
* Carbohydrates must first be oxidized to create reactive aldehydes * Aldehyde-activated carbohydrates can be reacted directly to primary amines (-NH2) or to labels activated with hydrazide groups (N-N)
36
Describe using carboxyl groups for conjugation labelling.
• Found on Gln, Glu, and at the C-terminus of each polypeptide chain • Usually outward facing on proteins and available for conjugation • Abundant, widely distributed and easily modified • Couple to primary amines after carboxyl activation - most commonly achieved with carbodiimides • EDC: 1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide
37
Provide an overview of antibody conjugation pros and cons.
Primary amines (–NH2) • Numerous and distributed over the entire antibody • K residues in the paratope region may affect binding (especially if adding a high density of labels) ``` Sulfhydryl groups (–SH) • Disulfides in the hinge region are most susceptible to reduction and can be selectively reduced • Provides consistent labeling at a defined location ``` Carbonyls (-CO) • Glycosylation sites are predominantly found in the Fc region of IgG • Results in labeled Ab with high activity Aldehydes (-CHO) Carboxyls (-COOH) • Not generally used to conjugate to Ab
38
Describe classes of cross-linkers.
Homobifunctional • Two identical functional groups • Can cause self-coupling of Ab • i.e. Glutaraldehyde Heterobifunctional • Two different functional groups, allowing 2-step reaction • Limits self-coupling, and thus polymer formation • Numerous types are available
39
Provide important considerations for conjugation.
Detectability • Can limit the sensitivity of an assay • Conjugation reaction (e.g. temp, pH) does not affect label Reactivity • The binding ability of reactants (i.e. Ab, Ag, biotin, avidin) need to be preserved after conjugation Nonspecific binding • Minimal binding of labeled reactants to solid phase Stability • Stable cross-linker under storage and reaction conditions
40
Describe the Biotin-Streptavidin system
• Based on the highly specific interaction of avidin with Biotin (Vitamin H/B7) • One of the strongest known non-covalent interaction between a ligand and protein (Ka=1015 M-1) • Biotin is small, so many molecules can be conjugated onto a single protein without affecting its function * Streptavidin (60 kDa protein purified from the Streptomyces avidinii) * Avidin (found in egg whites of birds, reptiles and amphibians) * Four biotin binding sites per molecule of avidin allowing for multiple assay configurations as well as signal amplification
41
List important considerations for choosing a label.
``` Need to consider several factors: • Health/environmental hazards (i.e. radioactivity) • Sensitivity • Stability/shelf life • Ability to automate • Need for special equipment ```